NEWS --
LOS ANGELES, CA, Apr 22, 2010 (MARKETWIRE via COMTEX) -- MMR Information
Systems, Inc. (OTCBB: MMRF) (MMR) disclosed today that it has entered into an
agreement with san ofi-aventis China, an arm of the world's third largest
pharmaceutical company in global prescription sales, regarding MMR's anti-CD20
monoclonal antibodies. The Company understands that these antibody assets may be
used in the development of future treatment options for various autoimmune and
B-Cell mediated diseases, which could include lupus nephritis, systemic lupus
erythematosus, psoriasis, inflammatory bowel disease, respiratory distress
syndrome, chronic lymphocytic leukemia, multiple sclerosis and vaculitis.
Dr. Bruce Garrett, President and Chief Operating Officer of GRSworldwide (GRS),
MMR's biotech consultants on its anti-CD20 antibody assets, based in Rockville,
Maryland, said, "These assets could show promise for treating a variety of
medical conditions, chief among them cancer, rheumatoid arthritis and
potentially others. Based on existing data, GRS believes this particular
formulary has the potential to become one of the b est anti-CD20 monoclonal
antibodies in its class."
Robert H. Lorsch, Chairman and CEO of MMR Information Systems, Inc., noted, "Our
primary business is the development, marketing and sales of the Company's
personal and professional health IT products, however, maximizing shareholder
value is always a primary focus. It now appears that monetizing pre-merger
assets such as the anti-CD20 antibodies and licensing the use of clinical trials
data and patient samples from FavId(R) trials, may represent a unique
opportunity to generate shareholder value that was not contemplated as part of
the Company's original post-merger business plan, particularly in the area of
cancer research."
Earlier this month, MMR signed an agreement with the Lymphoma Research
Foundation (LRF) under which the two organizations will work in good faith
regarding the use of pre-merger Favrille intellectual property, including more
than 150 lymphoma tumor sampl es accumulated by the Company as part of its
research on which more than $140 million dollars was spent on the development of
the FavId vaccine.
While the Company remains focused on its core business, including the
MyMedicalRecords Personal Health Record and MMRPro for physician practices, it
understands that clinical data and patient samples from the Company's trials may
be valuable to universities, biopharmaceutical companies and research
organizations, among other institutions. Additionally, the Company's anti-CD20
antibody assets could represent a potential candidate for the next generation
Rituximab. Rituximab, which is sold under the brand name Rituxan(R) in the
United States by Biogen Idec and Genentech (wholly owned member of the Roche
Group) and under the name MabThera(R) by Roche in the rest of the world except
Japan, where it is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd., is one of
the world's most successful monocl onal antibodies with reported 2009 sales of
USD $5.6 billion.
MMR INFORMATION SYSTEMS, INC.
MMR Information Systems, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal
Health Records ("PHRs") and electronic safe deposit box storage solutions,
serving consumers, healthcare professionals, employers, insurance companies,
unions and professional organizations and affinity groups. MyMedicalRecords
enables individuals and families to access their medical records and other
important documents, such as birth certificates, passports, insurance policies
and wills anytime from anywhere using the Internet. The MyMedicalRecords
Personal Health Record is built on proprietary, patented technologies to allow
documents, images and voicemail messages to be transmitted and stored in the
system using a variety of methods, including fax, phone, or file upload withoutrelying on any specific electronic medical record platform to populate a user's
account. The Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real time. MMR is
an Independent Software Vendor Partner with Kodak to deliver an integrated
turnkey EMR solution for healthcare professionals. MMR is also an integrated
service provider on Google Health. To learn more about MMR Information Systems,
Inc. and its products, visit www.mymedicalrecords.com and view the videos at
www.mymedicalrecordsonline.com/videos.
FORWARD-LOOKING STATEMENTS
Statements in this press release that are not strictly historical in nature
constitute "forward-looking statements." Such statements include, but are not
limited to, statements regarding the Company's assets including but not limited
to its primary Health IT bu sinesses, FavId and data from vaccine and clinical
trials, and anti-CD20 antibody assets. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors that may cause actual
results to be materially different from historical results or from any results
expressed or implied by such forward-looking statements. These factors include,
but are not limited to, risks and uncertainties related to the development and
approval of biotechnology/biopharmaceutical product candidates and Health IT
products and additional risks discussed in the Company's filings with the
Securities and Exchange Commission. All subsequent written and oral
forward-looking statements attributable to the Company (or any person acting on
the Company's behalf) are qualified by the cautionary statements in this notice.
MMR Information Systems, Inc. is providing this information as of the date of
this release and, except as required by law, doe s not undertake any obligation
to update any forward-looking statements contained in this release as a result
of new information, future events or otherwise.
CONTACT: Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz
SOURCE: MMR Information Systems, Inc.
CONTACT: mailto:bvolman@mmrmail.com
mailto:ms@publiccommunications.biz
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Internet
&n bsp; Computers and Software:Networking
Computers and Software:Software
Financial Services:Commercial and Investment Banking
Financial Services:Investment Services and Trading
Telecom:Networking
Medical and Healthcare:Facilities and Providers
&nbs p;Medical and Healthcare:Healthcare
Pharmaceuticals and Biotech:Biotech
Pharmaceuticals and Biotech:Trials
Professional Services:Purchasing
Financial Services:Venture Capital
